Literature DB >> 15633232

Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice.

Hai-Bo Zhou1, Juan-Juan Chen, Wen-Xia Wang, Jian-Ting Cai, Qin Du.   

Abstract

AIM: To investigate the apoptosis of implanted primary gastric cancer cells in nude mice induced by resveratrol and the relation between this apoptosis and expression of bcl-2 and bax.
METHODS: A transplanted tumor model was established by injecting human primary gastric cancer cells into subcutaneous tissue of nude mice. Resveratrol (500 mg/kg, 1,000 mg/kg and 1,500 mg/kg) was directly injected beside tumor body 6 times at an interval of 2 d. Then changes of tumor volume were measured continuously and tumor inhibition rate of each group was calculated. We observed the morphologic alterations by electron microscope, measured the apoptotic rate by TUNEL staining method, detected the expression of apoptosis-regulated genes bcl-2 and bax by immunohistochemical staining and PT-PCR.
RESULTS: Resveratrol could significantly inhibit carcinoma growth when it was injected near the carcinoma. An inhibitory effect was observed in all therapeutic groups and the inhibition rate of resveratrol at the dose of 500 mg/kg, 1,000 mg/kg and 1,500 mg/kg was 10.58%, 29.68% and 39.14%, respectively. Resveratrol induced implanted tumor cells to undergo apoptosis with apoptotic characteristics, including morphological changes of chromatin condensation, chromatin crescent formation, nucleus fragmentation. The inhibition rate of 0.2 mL of normal saline solution, 1,500 mg/kg DMSO, 500 mg/kg resveratrol, 1 000 mg/kg resveratrol, and 1 500 mg/kg resveratrol was 13.68+/-0.37%, 13.8+/-0.43%, 48.7+/-1.07%, 56.44+/-1.39% and 67+/-0.96%, respectively. The positive rate of bcl-2 protein of each group was 29.48+/-0.51%, 27.56+/-1.40%, 11.86+/-0.97%, 5.7+/-0.84% and 3.92+/-0.85%, respectively by immunohistochemical staining. The positive rate of bax protein of each group was 19.34+/-0.35%, 20.88+/-0.91%, 40.02+/-1.20%, 45.72+/-0.88% and 52.3+/-1.54%, respectively by immunohistochemical staining. The density of bcl-2 mRNA in 0.2 mL normal saline solution, 1,500 mg/kg DMSO, 500 mg/kg resveratrol, 1,000 mg/kg resveratrol, and 1,500 mg/kg resveratrol decreased progressively and the density of bax mRNA in 0.2 mL normal saline solution, 1,500 mg/kg DMSO, 500 mg/kg resveratrol, 1,000 mg/kg resveratrol, and 1,500 mg/kg increased progressively with elongation of time by RT-PCR.
CONCLUSION: Resveratrol is able to induce apoptosis of transplanted tumor cells. This apoptosis may be mediated by down-regulating apoptosis-regulated gene bcl-2 and up-regulating the expression of apoptosis-regulated gene bax.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633232      PMCID: PMC4205418          DOI: 10.3748/wjg.v11.i2.280

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse.

Authors:  M Mahyar-Roemer; A Katsen; P Mestres; K Roemer
Journal:  Int J Cancer       Date:  2001-12-01       Impact factor: 7.396

2.  Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures.

Authors:  B Szende; E Tyihák; Z Király-Véghely
Journal:  Exp Mol Med       Date:  2000-06-30       Impact factor: 8.718

3.  Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis.

Authors:  Qing-Bai She; Chuanshu Huang; Yiguo Zhang; Zigang Dong
Journal:  Mol Carcinog       Date:  2002-04       Impact factor: 4.784

4.  Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels.

Authors:  Wei-Kuo Chang; Kuender D Yang; Hau Chuang; Jia-Tsong Jan; Men-Fang Shaio
Journal:  Clin Immunol       Date:  2002-08       Impact factor: 3.969

5.  Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2.

Authors:  Fuyan Sun; Shoichi Akazawa; Kazuyuki Sugahara; Simeru Kamihira; Eiji Kawasaki; Katsumi Eguchi; Takehiko Koji
Journal:  Arch Histol Cytol       Date:  2002-06

6.  Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

Authors:  M Konopleva; S Konoplev; W Hu; A Y Zaritskey; B V Afanasiev; M Andreeff
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

7.  Promotion of photodynamic therapy-induced apoptosis by the mitochondrial protein Smac/DIABLO: dependence on Bax.

Authors:  Jitsuo Usuda; Song-mao Chiu; Kashif Azizuddin; Liang-yan Xue; Minh Lam; Anna-Liisa Nieminen; Nancy L Oleinick
Journal:  Photochem Photobiol       Date:  2002-08       Impact factor: 3.421

8.  Expression of apoptosis-related proteins in Barrett's metaplasia-dysplasia-carcinoma sequence: a switch to a more resistant phenotype.

Authors:  C J van der Woude; P L M Jansen; A T G M Tiebosch; A Beuving; M Homan; J H Kleibeuker; H Moshage
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

9.  Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

Authors:  Theocharis Panaretakis; Katja Pokrovskaja; Maria C Shoshan; Dan Grandér
Journal:  J Biol Chem       Date:  2002-08-21       Impact factor: 5.157

10.  Negative correlation between the ratio of Bax to Bcl-2 and the size of tumor treated by culture supernatants from Kupffer cells.

Authors:  George G Chen; Paul B S Lai; Xu Hu; Isa K Y Lam; Ernest C W Chak; Ying S Chun; Wan Y Lau
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  36 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

3.  High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death.

Authors:  Jennifer T Fox; Srilatha Sakamuru; Ruili Huang; Nedelina Teneva; Steven O Simmons; Menghang Xia; Raymond R Tice; Christopher P Austin; Kyungjae Myung
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 4.  Resveratrol: challenges in translation to the clinic--a critical discussion.

Authors:  Lalita Subramanian; Sherry Youssef; Saswati Bhattacharya; Jason Kenealey; Arthur S Polans; Paul R van Ginkel
Journal:  Clin Cancer Res       Date:  2010-11-02       Impact factor: 12.531

5.  Induction of a reversible, non-cytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection.

Authors:  Ru Zhou; Masayuki Fukui; Hye Joung Choi; Bao Ting Zhu
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

6.  Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor.

Authors:  Narendra P Singh; Venkatesh L Hegde; Lorne J Hofseth; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Mol Pharmacol       Date:  2007-09-14       Impact factor: 4.436

7.  Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells.

Authors:  Md Asaduzzaman Khan; Han-Chun Chen; Xin-Xing Wan; Mousumi Tania; Ai-Hua Xu; Fang-Zhi Chen; Dian-Zheng Zhang
Journal:  Mol Cells       Date:  2013-02-26       Impact factor: 5.034

8.  Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Gautam Sethi; Parmeswaran Diagaradjane; Preetha Anand; Manoj K Pandey; Juri Gelovani; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2010-07-15       Impact factor: 7.396

9.  Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer.

Authors:  Christine L Hann; Vincent C Daniel; Elizabeth A Sugar; Irina Dobromilskaya; Sara C Murphy; Leslie Cope; Xue Lin; Jared S Hierman; Daniel L Wilburn; D Neil Watkins; Charles M Rudin
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 10.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.